First-in-human dose escalation clinical trial shows importance of biopolymer in enhancing anti-tumor efficacy.
Supplementary Fig S3. SQL70 biopolymer implantation must precede SQP33 delivery for maximum anti-tumor efficacy
No takes yet. Share an insight, caveat, or question.
Srinivasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: